RepliCel Life Sciences Inc.

OTCPK:REPC.F Voorraadrapport

Marktkapitalisatie: US$65.0

RepliCel Life Sciences Beheer

Beheer criteriumcontroles 3/4

RepliCel Life Sciences' CEO is Andrew Schutte, appointed in Nov 2022, has a tenure of 5.92 years. directly owns 26.77% of the company’s shares, worth $17.40. The average tenure of the management team and the board of directors is 2 years and 5.9 years respectively.

Belangrijke informatie

Andrew Schutte

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO2yrs
Eigendom CEO26.8%
Management gemiddelde ambtstermijn2yrs
Gemiddelde ambtstermijn bestuur5.9yrs

Recente managementupdates

Recent updates

CEO

Andrew Schutte (34 yo)

2yrs

Tenure

CA$8,917

Compensatie

Mr. Andrew Schutte serves as President, Chief Executive Officer & Director of RepliCel Life Sciences Inc. since November 28, 2022. He served as an Independent Director of RepliCel Life Sciences Inc. since...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Andrew Schutte
President2yrsCA$8.92k26.77%
$ 17.4
Kevin McElwee
Co-Founder & Chief Scientific Officer13.3yrsCA$30.00k2.04%
$ 1.3
Ben Austring
Chief Legal Officer2yrsCA$14.50k0.49%
$ 0.3
David Kwok
Chief Financial Officer1.3yrsgeen gegevensgeen gegevens

2.0yrs

Gemiddelde duur

Ervaren management: REPC.F's management team is considered experienced (2 years average tenure).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Andrew Schutte
President5.9yrsCA$8.92k26.77%
$ 17.4
David Hall
Independent Chairman of the Board13.9yrsCA$17.75k1.35%
$ 0.9
Jean Krutmann
Member of Clinical Advisory Boardno datageen gegevensgeen gegevens
Ross Davidson
Chairman of Clinical Advisory Board11.1yrsgeen gegevensgeen gegevens
Peter Lewis
Independent Director13.5yrsCA$14.45k0.96%
$ 0.6
R. Buckler
Director8.8yrsCA$240.85k0.010%
$ 0.007
Gary Boddington
Independent Director3.4yrsCA$16.25k0.48%
$ 0.3
Jamie MacKay
Director1.3yrsgeen gegevens15.44%
$ 10.0
Tsukasa Kumai
Member of Clinical Advisory Boardno datageen gegevensgeen gegevens
Akimichi Morita
Member of Clinical Advisory Board3.5yrsgeen gegevensgeen gegevens
Kunihiko Suzuki
Senior Strategic Advisor to Directors3.1yrsgeen gegevensgeen gegevens

5.9yrs

Gemiddelde duur

61.5yo

Gemiddelde leeftijd

Ervaren bestuur: REPC.F's board of directors are considered experienced (5.9 years average tenure).